Prudential PLC Has $1.42 Million Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Prudential PLC cut its position in iShares Biotechnology ETF (NASDAQ:IBB) by 23.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,750 shares of the financial services provider’s stock after selling 3,310 shares during the period. Prudential PLC’s holdings in iShares Biotechnology ETF were worth $1,421,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. HHM Wealth Advisors LLC lifted its position in iShares Biotechnology ETF by 200.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 150 shares in the last quarter. VSM Wealth Advisory LLC purchased a new position in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $30,000. Bradley & Co. Private Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $32,000. Newbridge Financial Services Group Inc. purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $33,000. Finally, Hager Investment Management Services LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter worth $34,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $117.16 on Monday. iShares Biotechnology ETF has a 1 year low of $114.46 and a 1 year high of $150.57. The company has a market capitalization of $5.28 billion, a PE ratio of 24.21 and a beta of 0.84. The business has a fifty day moving average price of $134.95 and a two-hundred day moving average price of $138.05.

iShares Biotechnology ETF Increases Dividend

The business also recently disclosed a dividend, which was paid on Friday, March 21st. Investors of record on Tuesday, March 18th were issued a dividend of $0.1212 per share. The ex-dividend date of this dividend was Tuesday, March 18th. This is an increase from iShares Biotechnology ETF’s previous dividend of $0.06.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.